{"entity":{"type":"insider","cik":"0001786372","url":"/insider/0001786372","json_url":"/insider/0001786372.json","name":"Parrish Jay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2020-05-15","last":"2021-04-05","span_basis":"filed_date"},"name_variants":[{"name":"Parrish Jay","source":"filing","n_filings":12,"first_seen":"2020-05-15","last_seen":"2021-04-05"}],"transactions":[{"id":4824726,"accession":"0001209191-21-025194","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-025194","line_url":"/filing/0001209191-21-025194#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6944.0,"shares_display":"6,944","price_per_share":51.4049,"price_display":"51.40","price_state":"stated","total_value":356955.6256,"total_display":"356,955.63","shares_owned_after":9260.0,"shares_owned_after_display":"9,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":4224025,"accession":"0001209191-21-016880","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-016880","line_url":"/filing/0001209191-21-016880#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6944.0,"shares_display":"6,944","price_per_share":63.4405,"price_display":"63.44","price_state":"stated","total_value":440530.832,"total_display":"440,530.83","shares_owned_after":9260.0,"shares_owned_after_display":"9,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5488181,"accession":"0001209191-21-006880","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-006880","line_url":"/filing/0001209191-21-006880#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6944.0,"shares_display":"6,944","price_per_share":69.9056,"price_display":"69.91","price_state":"stated","total_value":485424.4864,"total_display":"485,424.49","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider"},{"id":4221120,"accession":"0001209191-21-001158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-001158","line_url":"/filing/0001209191-21-001158#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6945.0,"shares_display":"6,945","price_per_share":26.3204,"price_display":"26.32","price_state":"stated","total_value":182795.178,"total_display":"182,795.18","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":3173920,"accession":"0001209191-20-061253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-061253","line_url":"/filing/0001209191-20-061253#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6945.0,"shares_display":"6,945","price_per_share":31.5288,"price_display":"31.53","price_state":"stated","total_value":218967.516,"total_display":"218,967.52","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-02","scope":"insider"},{"id":2444823,"accession":"0001209191-20-056681","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-056681","line_url":"/filing/0001209191-20-056681#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6944.0,"shares_display":"6,944","price_per_share":31.272,"price_display":"31.27","price_state":"stated","total_value":217152.768,"total_display":"217,152.77","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":3117116,"accession":"0001209191-20-053260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-053260","line_url":"/filing/0001209191-20-053260#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6945.0,"shares_display":"6,945","price_per_share":34.7504,"price_display":"34.75","price_state":"stated","total_value":241341.528,"total_display":"241,341.53","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":2587577,"accession":"0001209191-20-049394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049394","line_url":"/filing/0001209191-20-049394#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6943.0,"shares_display":"6,943","price_per_share":39.1468,"price_display":"39.15","price_state":"stated","total_value":271796.2324,"total_display":"271,796.23","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider"},{"id":2731650,"accession":"0001209191-20-044748","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-044748","line_url":"/filing/0001209191-20-044748#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11110.0,"shares_display":"11,110","price_per_share":47.6511,"price_display":"47.65","price_state":"stated","total_value":529403.721,"total_display":"529,403.72","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-04","scope":"insider"},{"id":2832684,"accession":"0001209191-20-040664","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-040664","line_url":"/filing/0001209191-20-040664#line-3","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":37.9508,"price_display":"37.95","price_state":"stated","total_value":2846310.0,"total_display":"2,846,310.00","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider"},{"id":2510015,"accession":"0001209191-20-033780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-033780","line_url":"/filing/0001209191-20-033780#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":35.2188,"price_display":"35.22","price_state":"stated","total_value":2641410.0,"total_display":"2,641,410.00","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":2246573,"accession":"0001209191-20-029859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-029859","line_url":"/filing/0001209191-20-029859#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001786372","owner_name":"Parrish Jay","owner_url":"/insider/0001786372","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":30.0518,"price_display":"30.05","price_state":"stated","total_value":2253885.0,"total_display":"2,253,885.00","shares_owned_after":222222.0,"shares_owned_after_display":"222,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Officer (Chief Business Officer)","n_filings":12,"first_seen":"2020-05-15","last_seen":"2021-04-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001786372","retrieved_at":"2026-08-22T00:32:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}